Objective: The goal of the study was to determine the association between levels of Anti-Mullerian hormone (AMH) and sexual dysfunction in infertile women.
Methods: This prospective cross-sectional study was done on 558 infertile women. The participants were divided into three different AMH groups i.e. first AMH group (poor responder with ≤3 oocytes), second AMH group (normoresponder with 4–9 oocytes), and third AMH group (high responder with ≥10 oocytes). The values of the total Female Sexual Function Index (FSFI) variable were divided into three FSFI levels: level 1 (below 23), level 2 (between 23 and 29), and Level 3 (above 30). The participants were divided into two groups: the first group with normal weight (BMI<25) and the second group with overweight (25<BMI<30). The FSFI questionnaire as a standardized and validated self-report was applied for measurement of the female sexual dysfunction.
Results: Participants had a mean age of 30.14 years and a mean BMI of 24.81. 64.87% of the participants were overweight and 35.13% were overweight. 55.4 percent of the participants are at level 1, 42.3 percent at level 2, and 2.3 percent at level 3 with respect to the overall FSFI stages. The average of the first AMH group was 0.58±0.27, the mean of the second AMH group was 2.38±0.89, and the mean of the third group was 6.42±1.58. There was a substantial difference in terms of all the total FSFI subdomains between the three AMH classes. The overall FSFI level 1 participants had a p-value=0.00, those at level 2 had a p-value=0.00, and those at level 3 had a p-value=0.005.
Conclusion: AMH is inversely associated with sexual dysfunction. The overweight participants had a higher AMH value. Sexual therapy, identifying the factors causing sexual dysfunction, and offering sufficient care are important to resolve female sexual dysfunction among infertile women.
Please see the link :- https://www.journalarjgo.com/index.php/ARJGO/article/view/30134
No comments:
Post a Comment